
    
      Antineoplastic therapies are responsible of a wide range of cardio-vascular side effects.The
      investigators use VigiBase, the World Health Organization (WHO) database of individual safety
      case reports, to identify cases of cardiovascular adverse drug reactions following treatment
      with antineoplastic and immunomodulating agents
    
  